Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Baier, K; Cvirn, G; Fritsch, P; Köstenberger, M; Gallistl, S; Leschnik, B; Muntean, W.
Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
PEDIAT RES. 2005; 57(5 Pt 1): 685-689.
Doi: 10.1203/01.PDR.0000156515.49293.F8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Muntean Eugen
- Co-Autor*innen der Med Uni Graz
- Cvirn Gerhard
- Fritsch Peter
- Gallistl Siegfried
- Koestenberger Martin
- Leschnik Bettina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Neonatal plasma clots slower than adult plasma, and only 30-50% of peak adult thrombin activity can be produced in neonatal plasma when high amounts of tissue factor (TF) are added to trigger clotting, as used in standard clotting assays. Plasma activation by addition of low amounts of TF probably better reflects conditions in vivo. Under these conditions, cord plasma clots faster than adult plasma. In the present study, we show that after activation with low amounts of TF, higher amounts of the anticoagulants heparin and hirudin are required in cord plasma for effective inhibition of thrombin generation compared with adult plasma. After strong activation with high amounts of TF (30 microM), the thrombin potential was significantly more suppressed in cord plasma compared with adult plasma in the presence of 0.4 IE/mL heparin (-92 versus -75%; p < 0.01) and in the presence of 2 IE/mL hirudin (-18 versus -8%; p < 0.01). In contrast, after weak activation with low amounts of TF (30 pM), the thrombin potential was significantly more suppressed in adult plasma compared with neonatal plasma in the presence of 0.025 IE/mL heparin (-93 versus -8%; p < 0.01) and in the presence of 2 IE/mL hirudin (-89 versus -48%; p < 0.01). Our results show that in neonates, effects of anticoagulants very much depend on the type of activation used to initiate clotting, and doses of anticoagulants should not be derived from studies done in adults, because potentially higher doses of anticoagulants may be required.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Age Factors -
- Anticoagulants - pharmacology
- Antithrombins - metabolism
- Blood Coagulation - drug effects
- Blood Coagulation Tests - drug effects
- Dose-Response Relationship, Drug - drug effects
- Fetal Blood - metabolism
- Fibrinolytic Agents - pharmacology
- Heparin - pharmacology
- Hirudins - pharmacology
- Humans - pharmacology
- Infant, Newborn - pharmacology
- Thrombin - antagonists and inhibitors
- Thromboplastin - metabolism